Elsbernd Brian

CIK 00017635111 companyCORAL GABLES, FL

SEC Profile

Transactions

Companies

Filings

CIK

0001763511

Recent Transactions

50 trades

Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−147,621→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−126,704→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2026-07-15$31.50/sh−242,501→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−132,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−200,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−135,000→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−29,776→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−10,322→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2026-07-15−7,067→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−98,652→ 0 total
Disposition to Issuer
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2026-07-15−69,000→ 0 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-29+6,667→ 245,124 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-29−6,667→ 956,142 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-29−2,623→ 242,501 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08−2,780→ 238,457 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-12-08−7,067→ 962,809 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-12-08+7,067→ 241,237 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21−2,030→ 234,170 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-21+5,161→ 236,200 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-21−5,161→ 969,876 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to purchase common stock
2025-11-20+98,652→ 945,161 total
Award
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-11-20+29,776→ 975,037 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-11-12$22.70/sh+40,000→ 231,039 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2025-09-08−112,475→ 846,609 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-08$2.24/sh+112,475→ 301,039 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-08$20.30/sh−30,000→ 271,039 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-04$2.24/sh+30,000→ 218,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2025-09-04−30,000→ 959,084 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-04$19.52/sh−30,000→ 188,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2025-09-03−20,000→ 989,084 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-03$2.24/sh+20,000→ 208,564 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-09-03$20.08/sh−20,000→ 188,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-03-03$2.24/sh+53,255→ 241,819 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2025-03-03−9,270→ 1,062,339 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-03-03$23.23/sh−9,720→ 188,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-03-03$2.24/sh+9,270→ 197,834 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2025-03-03−53,255→ 1,009,084 total
Sale
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-03-03$22.93/sh−53,255→ 188,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2025-02-14−9,667→ 1,071,609 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14−2,353→ 188,564 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2025-02-14+9,667→ 190,917 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27+6,667→ 183,191 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-27−1,941→ 181,250 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-27−6,667→ 1,081,276 total
Tax Payment
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09−1,720→ 176,524 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-12-09+7,067→ 178,244 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Restricted Stock Units
2024-12-09−7,067→ 1,087,943 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Common Stock, par value $0.001 per share
2024-11-26$4.01/sh+50,244→ 174,677 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2024-11-26−9,756→ 1,095,010 total
Exercise/Conversion
CATALYST PHARMACEUTICALS, INC.$CPRX
Options to Purchase Common Stock
2024-11-26−50,244→ 1,104,766 total

Companies

CATALYST PHARMACEUTICALS, INC.
Chief Legal Officer
$CPRX

Recent Filings

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134

View on SEC.gov